Pharmacy

Healthcare improvement company Premier Inc. established a new company aimed at ensuring health systems have continuous and affordable access to medications, particularly those that lack competition or are in shortage.

Adding to a wave of high-level departures, Sean Bohen, MD, PhD, AstraZeneca's CMO and executive vice president of global medicines development, will leave the company, according to Bloomberg.

The American Hospital Association submitted several legislative, regulatory and best practice recommendations to the FDA Jan. 11 for managing new and chronic prescription drug shortages.

GoodRx is offering all federal employees affected by the government shutdown an exclusive discount on their prescription medications, according a company blog post.

After several conflict-of-interest scandals, Memorial Sloan Kettering Cancer Center in New York City will bar top executives from serving on corporate boards of drug and healthcare companies that pay them, according to The New York Times.

In recent months, several drug giants announced they are exploring deals or have completed deals to expand their portfolios of cancer medications.

Drug giant Eli Lilly will cut 250 jobs at its factory in Eastern France, according to Reuters.

Patients for Affordable Drugs, affordable drug advocates, will launch a $1 million ad campaign to help one of the Trump administration's drug-pricing proposals gain traction, according to STAT.

Snehal Doshi, PharmD, vice president of pharmacy services for Marietta, Ga.-based WellStar Health System, spoke with Becker's Hospital Review about the disruptors that have his attention and the skills pharmacy leaders need in today's rapidly changing healthcare climate.

Louisiana officials will proceed with establishing a Netflix-style payment model for hepatitis C treatments, STAT reports.